Opinion

Video

Best Practices for Biomarker Testing in Metastatic Melanoma

When a patient with metastatic melanoma patient tests negative for the BRAF V600E mutation, doctors recommend sending the sample for next-generation sequencing testing which can take 2-3 weeks, during which time they may start immunotherapy if the patient has aggressive disease, but ideally should wait for results to guide treatment.

Related Videos
5 KOLs are featured in this series.
5 KOLs are featured in this series.
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Thach-Giao Truong, MD, medical director, Melanoma Program, Cleveland Clinic
5 KOLs are featured in this series.